We translate nuanced reimbursement and policy issues for private-equity firms and other investors and lenders in the health care and biosciences sectors. We provide "due diligence" assessments, deconstruct targeted issues, and perform related advisory services.

Examples

  • Assessments of the health care policy environment.

  • Analyses of the consequences of announced or potential
    governmental actions.

  • Ongoing review, monitoring, and reporting on
    issues affecting investment decisions.